About this trial
The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory cells removed, injured tissue cells replaced, and capillary barrier function re-established. Macrophages are key players in all of these. Here the investigators hypothesize that resident alveolar macrophages and recruited macrophages serve completely different functions, acting independently (i.e. division of labor) yet cooperatively (synergism).
Eligibility criteria
Qualifiers
Written, informed consent
Age 18-50
Disqualifiers
Current or recent illness (past 2 weeks)
Presence or prior history of cardiac, pulmonary or systemic disease
Bleeding disorder, use of systemic anticoagulants or antiplatelet therapy
American Society of Anesthesiology (ASA) class 2 or greater
Trial design
Treatments tested in this trial
- bronchoscopy with intrabronchial administration of lipopolysaccharide